FDA Recalls DePuy Hip Replacement Devices

May 13, 2013 | Thomas L. Stroble
FDA Recalls DePuy Hip Replacement Devices

May 13, 2013

Due to numerous complications associated with the DePuy ASR Hip Resurfacing System and the ASR XL Acetabular System, the U.S. Food and Drug Administration (FDA) has initiated a voluntary recall on the devices. The DePuy Hip Replacement Recall began in August of 2010, but numerous patients continue to report problems today.

According to an article from DrugWatch, the recall was implemented after several studies showed an excessive failure rate of the metal-on-metal hip implants compared to plastic and ceramic designs. Experts believe as many as 40 percent of all ASR devices will fail within five-years of use.

Some of the problems with the devices that have been reported include:

  • Swelling and inflammation at the site of implantation
  • Hip pain
  • Loosening of the cup
  • Metallosis

Many metal-on-metal hip replacement recipients in need of revision surgery, and medical bills associated with the procedure can sometimes be quite large.

Recipients of metal hip implants may be wondering what they should do if they begin to have problems with their device. Discussing available legal options with an attorney may be in an individual’s best interests if they are considering filing for compensation due to a failed hip implant.

The Michigan Personal Injury Attorneys with Michigan Injury Lawyers may be able to help anyone who has suffered because of a failed hip implant device.

Thomas L. Stroble Author Image

Thomas L. Stroble


Mr. Stroble is a highly accomplished graduate of Michigan State University, with degrees in both science and law. He specializes in commercial lawsuits and personal injury cases. Licensed to practice law in Michigan and even the U.S. Supreme Court, he’s a well-qualified legal expert. Besides his career in law, he loves outdoor activities and volunteers as a part-time police officer in Birmingham.

Author's Bio

You Might Be Also Interested In